Evidence map›Paper›PMID 36975385›Full record

ArticleDermatopathology (Basel, Switzerland)2023

Synthesis and Physiological Remodeling of CD34 Cells in the Skin following the Reversal of Fibrosis through Intensive Treatment for Lower Limb Lymphedema: A Case Report.

Jose Maria Pereira de Godoy, Ana Carolina Pereira de Godoy, Maria de Fatima Guerreiro Godoy, Dalisio de Santi Neto

Open access · goldFull text readCase Reports
In one paragraph

Article in Dermatopathology (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jose Maria Pereira de GodoyDepartment of the Medicine School, São José do Rio Preto (FAMERP), CNPq (National Council for Research and Development), Sao Jose do Rio Preto 15090-000, Brazil.ORCID 0000-0001-5424-7787
Ana Carolina Pereira de GodoyResearch Group of the Clínica Godoy, Intensive Surgery Pediatric Cardiac, Hospital da Criança e Maternidade-HCM, Medicine School of Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto 15090-000, Brazil.
Maria de Fatima Guerreiro GodoyResearch Group in the Clínica Godoy, Medicine School of São José do Rio Preto (FAMERP), Sao Jose do Rio Preto 15090-000, Brazil.ORCID 0000-0003-3725-7961
Dalisio de Santi NetoHospital de Base, Medicine School of São José do Rio Preto (FAMERP), Sao Jose do Rio Preto 15090-000, Brazil.
Faculdade de Medicina de São José do Rio Preto · BRNational Council for Scientific and Technological Development · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel type of cell underwent identification between 2005 and 2008 and was denominated the "telocyte" in 2010. In 2012, transmission electron microscopy revealed the presence of telocytes in the dermis. The aim of the present study was to report important changes in immunostained CD34 cells following the treatment of lower limb lymphedema using a specific lymphatic therapy technique. A clinical trial involving the evaluation of changes in immunostained CD34 cells in the epidermis and dermis (10 randomly selected histological fields) of a patient before and after intensive treatment for clinical stage II lymphedema was conducted using the Godoy Method, which was adapted to the treatment of skin fibrosis. The evaluation involved the use of the Weibel multi-point morphometric method. Comparisons were performed using the

Indexed as

CD34fibrosisskintelocytestreatment

Identifiers

PMID36975385
PMCPMC10047408
OpenAlexW4323663125

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read11
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.